What is the dosage of testosterone suspension?

Concentration and mL per dose
SourceProductStrength
Kalra narrative review, Indian market table1Testosterone suspension, intramuscularNo mg/mL given
Depo-Testosterone label2Testosterone cypionate in oil, a different product100 mg/mL and 200 mg/mL

A narrative review by Kalra and colleagues lists intramuscular testosterone suspension at 25-50 mg q7-14 days in its table of preparations in the Indian market; no US label for an aqueous suspension turned up.1

Concentration and mL per dose

The table is set at the top of the page

No US label, and no mg/mL from a label or maker for a ready aqueous testosterone suspension, turned up in DailyMed and web searches; Indian and UK or EU regulator pages were not searched. Without a sourced concentration, no mL per dose or syringe mark can be worked for a suspension, so this guide gives none. The 100 mg/mL and 200 mg/mL strengths on the Depo-Testosterone label belong to testosterone cypionate in oil, a different product, and are not a suspension's strength.2 Whether a suspension needs any mixing is not sourced either.

Dose and schedule by source

The suspension doses here come from a narrative review; the two labels are for esters in oil, and the Depo-Testosterone label says esters in oil injected intramuscularly are absorbed slowly from the lipid phase, so cypionate can be given at intervals of two to four weeks.12

SourceProductDose and schedule
Kalra narrative review, Indian market table1Suspension, intramuscular25-50 mg q7-14 days
Depo-Testosterone label2Cypionate in oil, intramuscular50-400 mg every two to four weeks, for replacement in the hypogonadal male
Enanthate label3Enanthate in sesame oil50 to 400 mg every 2 to 4 weeks, as replacement therapy in male hypogonadism

The enanthate label adds that, in general, total doses above 400 mg per month are not required because of the prolonged action of its oil preparation.3 The Depo-Testosterone label says its suggested dosage varies depending on the age, sex, and diagnosis of the individual patient.2 No trial of an aqueous suspension turned up in ClinicalTrials.gov; PubMed holds only title records, among them Freed 1946 and Ragab and El-Itribi (ten cases of male hypogonadism and impotence), so no dose, size by arm or length can be read from them.45 Too few people logged testosterone suspension for Milligram to give a share.

Storage

The Depo-Testosterone label, for an oil solution, says to store at 20° to 25°C and protect from light.2 No storage or shelf-life data for an aqueous suspension, before or after first use, turned up. An assay paper on testosterone in an aqueous suspension says testosterone appears to be a very stable drug since it did not decompose significantly, even on heating; it gives no shelf life or storage conditions.6

Frequently asked questions

What is the half-life of testosterone suspension?

No half-life for an aqueous suspension turned up in labels. The cypionate label gives about eight days for that oil ester injected intramuscularly.2 The enanthate label says reported half-lives of testosterone itself vary considerably, ranging from 10 to 100 minutes.3

How is testosterone suspension injected?

The Depo-Testosterone label, for an oil solution, says intramuscular use only, deep in the gluteal muscle.2 The narrative review lists testosterone suspension as an intramuscular injection, without naming a site.1

What is the testosterone suspension dosage for women?

No label or trial for an aqueous suspension in women turned up. The enanthate label gives 200 to 400 mg every 2 to 4 weeks for palliation of inoperable mammary cancer in women.3 The same label says women with metastatic breast carcinoma must be followed closely because androgen therapy occasionally appears to accelerate the disease.3

References

  1. PubMed Central. Counselling for Testosterone Therapy in Mid Life Men. 2022. pmc.ncbi.nlm.nih.gov
  2. DailyMed. Depo ® -Testosterone testosterone cypionate injection, USP CIII. 2026. dailymed.nlm.nih.gov
  3. DailyMed. TESTOSTERONE ENANTHATE INJECTION, USP. 2026. dailymed.nlm.nih.gov
  4. PubMed. Therapeutic use of testosterone in aqueous suspension. 1946. pubmed.ncbi.nlm.nih.gov
  5. PubMed. Perandren therapy with tablet implants and crystals in aqueous suspension in ten cases of male hypogonadism and impotence. 1949. pubmed.ncbi.nlm.nih.gov
  6. PubMed. Quantitation of testosterone in a suspension using high-performance liquid chromatography. 1999. pubmed.ncbi.nlm.nih.gov